Cargando…
Thrombolysis in an acute ischemic stroke patient with rivaroxaban anticoagulation: A case report
RATIONALE: Whether intravenous recombinant tissue plasminogen activator (r-TPA) therapy can be administered in acute ischemic stroke patients treated with novel oral anticoagulants (NOACs), including rivaroxaban, remains controversial. PATIENT CONCERNS: A 76-year-old woman with nonvalvular atrial fi...
Autores principales: | Chao, Yen-Tung, Hu, Chaur-Jong, Chan, Lung |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6408142/ https://www.ncbi.nlm.nih.gov/pubmed/30813169 http://dx.doi.org/10.1097/MD.0000000000014560 |
Ejemplares similares
-
No Time to Lose: Cases of Anticoagulant Reversal Before Thrombolysis in Acute Ischemic Stroke Patients
por: Amin, Sheyar, et al.
Publicado: (2022) -
SOP: thrombolysis in ischemic stroke under oral anticoagulation therapy
por: Kermer, Pawel, et al.
Publicado: (2022) -
Pre-treatment of Single and Double Antiplatelet and Anticoagulant With Intravenous Thrombolysis for Older Adults With Acute Ischemic Stroke: The TTT-AIS Experience
por: Lin, Sheng-Feng, et al.
Publicado: (2021) -
Intravenous Thrombolysis in a Stroke Patient Receiving Rivaroxaban
por: Fluri, Felix, et al.
Publicado: (2013) -
Corrigendum: Pre-treatment of Single and Double Antiplatelet and Anticoagulant With Intravenous Thrombolysis for Older Adults With Acute Ischemic Stroke: The TTT-AIS Experience
por: Lin, Sheng-Feng, et al.
Publicado: (2021)